• Subscribe
  • Magazine
  • Past Issues
  • Surveys
  • Industry Statistics
  • About Us
  • Members Only
  • Best Places to Work
    • Recent Quotes
    My Watchlist
    Indicators
    PennEnergy Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Vaneck Biotech ETF (NQ: BBH )

    181.74 +0.94 (+0.52%)
    Official Closing Price Updated: 4:15 PM EDT, Aug 23, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 5,317
    Open 181.51
    Bid (Size) 181.65 (1)
    Ask (Size) 181.88 (1)
    Prev. Close 180.80
    Today's Range 180.84 - 182.40
    52wk Range 142.51 - 182.93
    Shares Outstanding N/A
    Dividend Yield 0.41%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    VanEck Announces Year-End Distributions for VanEck Equity ETFs
    From VanEck
    Via Business Wire
    Time For Gilead Sciences-Heavy ETFs?
    Gilead Sciences has underperformed the broader market this year by a hefty margin. 
    Via Talk Markets

    Performance

    YTD
    +7.33%
    +7.33%
    1 Month
    +2.52%
    +2.52%
    3 Month
    +8.14%
    +8.14%
    6 Month
    +9.62%
    +9.62%
    1 Year
    +13.01%
    +13.01%

    More News

    Read More
    Mifepristone Abortion Pill Access in Limbo: Justice Department May Ask Supreme Court's Intervention
    Via Benzinga
    Women's Reproductive Rights: US Court Preserves Access To Abortion Pill For Now, But With Tighter Rules
    Via Benzinga
    New York and California Prepare For Potential Mifepristone Ban In Texas With Stockpiling Of Alternative Abortion Medications
    Via Benzinga
    Attorney Generals of Over 20 States Sound Alarm Over Suspension Of Abortion Med Approval: "Devastating Risks" Ahead
    Via Benzinga
    FDA Withdraws Lone Premature Birth Drug Makena Over Lack of Proven Benefits
    Via Benzinga
    VanEck Launches Robotics ETF (IBOT)
    From VanEck
    Via Business Wire
    US Judge Weighs Nationwide Ban On Abortion Pills
    Via Benzinga
    FDA Takes Action To Restrict Unlawful Import Of Animal Tranquilizer 'Tranq' Or ''Zombie Drug'
    Via Benzinga
    3 Best Funds for Aggressive Investors
    Via InvestorPlace
    Progenity Is Unlikely to Live Up to Its IPO Hype
    Via InvestorPlace
    Economic Hurricane Ahead? 7 Profitable Places to Hide Your Money
    Via InvestorPlace
    How Are Biotech ETFs Reacting To These Q3 Earnings Releases?
    Via Talk Markets
    Novavax Stock Is a Buy for Long-Term Investors on Its Pipeline Alone
    Via InvestorPlace
    Take A Look At The Top-Performing Biotech ETFs YTD
    Via Talk Markets
    Exposures COVID-19
    Biotech ETFs To Benefit From Latest Booster Update
    Via Talk Markets
    Exposures COVID-19
    ETF Investing Areas to Consider for August
    Via Talk Markets
    Moderna ETFs To Rise On Positive COVID-19 Vaccine Updates
    Via Talk Markets
    Exposures COVID-19
    5 Top ETFs With Exposure To Biogen
    Via Talk Markets
    5 Top ETFs With Exposure To Biogen
    Via Benzinga
    Exposures Product Safety
    Biotech ETFs To Suffer As US Backs IP Waiver For COVID-19 Vaccines
    Via Talk Markets
    Topics Intellectual Property
    Exposures COVID-19 Intellectual Property
    Moderna Stock Moves After Q1 Print: Technical Levels For The COVID-19 Vaccine Play
    Via Benzinga
    Exposures COVID-19
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.